United States ex rel. Hirt v. Walgreen Co.

Decision Date25 January 2017
Docket NumberNo. 16-6232,16-6232
Citation846 F.3d 879
Parties UNITED STATES of America ex rel. Andrew Hirt, Relator–Appellant, v. WALGREEN COMPANY, Defendant–Appellee.
CourtU.S. Court of Appeals — Sixth Circuit

ON BRIEF: G. Kline Preston IV, KLINE PRESTON LAW GROUP, P.C., Nashville, Tennessee, for Appellant. Frederick Robinson, NORTON ROSE FULBRIGHT US LLP, Washington, D.C., for Appellee.

Before: SUHRHEINRICH, SUTTON, and MCKEAGUE, Circuit Judges.

OPINION

SUTTON, Circuit Judge.

Andrew Hirt, owner of Andy's Pharmacies, alleges that Walgreen Company distributed kickbacks to Medicare and Medicaid recipients when they transferred their prescriptions to Walgreens. By sending these fraudulent insurance claims to the government, Hirt maintains that Walgreens violated the False Claims Act, and he filed this qui tam claim as a result. The district court rejected Hirt's claim as a matter of law. Because Hirt failed to state his claim with particularity, as Civil Rule 9(b) requires, we affirm.

Hirt owns two pharmacies, one of which is located in Cookeville, Tennessee. His Cookeville pharmacy competes with a Walgreens in the area. Between November 19, 2012 and August 25, 2014, Hirt alleges that the Willow Walgreens offered $25 gift cards to lure his customers to Walgreens in violation of the Anti–Kickback Statute, 42 U.S.C. § 1320a–7b(b), and that Walgreens submitted the resulting prescription-drug claims by Medicare and Medicaid recipients to the government in violation of the False Claims Act, 31 U.S.C. § 3729.

Hirt filed this qui tam action under the whistleblower provision of the False Claims Act on behalf of himself and the United States. The government declined to intervene in the action, and Walgreens moved to dismiss it. The district court granted the motion, holding (among other things) that Hirt failed to state his claims with sufficient particularity under Civil Rule 9(b).

The False Claims Act imposes civil liability for "knowingly present[ing] ... a false or fraudulent claim" to the government "for payment or approval." 31 U.S.C. § 3729(a)(b). The statute provides for public enforcement and private (qui tam ) lawsuits. Id. § 3730(b). At the same time that the statute encourages whistleblowers, it discourages "opportunistic" plaintiffs who "merely feed off a previous disclosure of fraud." U.S. ex rel. Poteet v. Medtronic, Inc. , 552 F.3d 503, 507 (6th Cir. 2009). For that reason, individual plaintiffs cannot bring qui tam complaints based upon information already in the public domain. See 31 U.S.C. § 3730(e)(4). But if they can show that they are an original source of the information—someone "who has knowledge that is independent of and materially adds" to the prior public disclosure—the public-disclosure bar does not apply. Id. ; see U.S. ex rel. Advocates for Basic Legal Equal., Inc. v. U.S. Bank, N.A. , 816 F.3d 428, 430 (6th Cir. 2016).

In addition to satisfying the False Claims Act's requirements, qui tam plaintiffs must meet the heightened pleading standards of Civil Rule 9(b). U.S. ex rel. Bledsoe v. Cmty. Health Sys., Inc. , 501 F.3d 493, 503 (6th Cir. 2007). In all averments of "fraud or mistake," the plaintiff must state with "particularity the circumstances constituting fraud or mistake." Fed. R. Civ. P. 9(b). The identification of at least one false claim with specificity is "an indispensable element of a complaint that alleges a [False Claims Act] violation in compliance with Rule 9(b)." Bledsoe , 501 F.3d at 504. Adherence to this requirement not only respects Civil Rule 9(b), but it also helps in determining whether the public-disclosure bar applies.

Hirt has not met this standard. His complaint does not identify a single false claim. He describes the unlawful distribution of gift cards in general but not the submission of any claims obtained with those gift cards. All that Hirt says is that "his [Medicaid and Medicare] customers accepted the $25.00 gift cards to move their business to (Willow) Walgreens in Cookeville during the period November 19, 2012 through August 25, 2014," and that Walgreens "induce[d] ... false or fraudulent claims to the United States Government for the payment of pharmaceuticals." R. 29 at 5, 9. But he does not identify any false claim arising from any of those (allegedly) induced customers. He does not tell us the names of any such customers or their initials. He does not tell us the dates on which they filled prescriptions at Walgreens. He does not tell us the dates on which Walgreens filed the reimbursement claims with the government. He does not, indeed, even say that these unnamed customers filled any prescriptions at Walgreens at all, let alone that Walgreens processed them and filed reimbursement claims with the government. We are left to infer these essential elements from the fact that Hirt's customers moved their business from his pharmacies. But inferences and implications are not what Civil Rule 9(b) requires. It demands specifics—at least if the claimant wishes to raise allegations of fraud against someone.

Relying on an unpublished decision from the Eleventh Circuit, we raised the possibility in 2007 of "relaxing" the requirement that a plaintiff identify at least one false claim with particularity if that plaintiff, through no fault of his own, "cannot allege the specifics of actual false claims that in all likelihood exist." Bledsoe , 501 F.3d at 504 n.12. But we did not resolve the point, ultimately "express[ing] no opinion as to the contours or existence of any such exception." Id. In two later decisions, we repeated the "relax" language. Chesbrough v. VPA, P.C. , 655 F.3d 461, 471 (6th Cir. 2011) ; U.S. ex rel. Prather v. Brookdale Senior Living Comtys., Inc. , 838 F.3d 750, 769 (6th Cir. 2016). The Eleventh Circuit's use of the word "relax," and our repetition of it in later cases, runs the risk of misleading lawyers and their clients. We have no more authority to "relax" the pleading standard established by Civil Rule 9(b) than we do to increase it. Only by following the highly reticulated procedures laid out in the Rules Enabling Act can anyone modify the Civil Rules, whether in the direction of relaxing them or tightening them. See 28 U.S.C. §§ 2071 –2077. To the extent the words of Civil Rule 9(b) need elaboration, and it's not obvious that they do, the most that can be said is that "particular" allegations of fraud may demand different things in different contexts.

In practice, we have applied the "relax[ed]" standard just once, and that application has no purchasing power here. See Prather , 838 F.3d at 769. Prather's allegations satisfied the particularity requirement because she had sufficient personal knowledge of the defendant's claims submission and billing processes. Her job required her to review the company's Medicare claims documentation to ensure compliance with state and federal insurance guidelines. Id. at 770. This review took...

To continue reading

Request your trial
36 cases
  • Duramax Diesel Litig. Andrei Fenner v. Gen. Motors, LLC
    • United States
    • U.S. District Court — Eastern District of Michigan
    • 20 Febrero 2018
    ...particularity requirement. See Counts v. General Motors, LLC , 237 F.Supp.3d 572 (E.D. Mich. 2017) (citing United States v. Walgreen Co. , 846 F.3d 879, 880– 81 (6th Cir. 2017) ). That said, the Sixth Circuit has recognized that " ‘particular’ allegations of fraud may demand different thing......
  • Counts v. Gen. Motors, LLC
    • United States
    • U.S. District Court — Eastern District of Michigan
    • 14 Febrero 2017
    ...have no more authority to ‘relax’ the pleading standard established by Civil Rule 9(b) than we do to increase it." No. 16–6232, 846 F.3d 879, 881–82 (6th Cir. 2017). The court continued: "To the extent the words of Civil Rule 9(b) need elaboration, ... the most that can be said is that ‘par......
  • Cnty. of Monroe v. Purdue Pharma L.P. (In re Nat'l Prescription Opiate Litig.)
    • United States
    • U.S. District Court — Northern District of Ohio
    • 30 Abril 2020
    ...less of the pleader." Charles Alan Wright et al. , 5A Fed. Prac. & Proc. Civ. § 1298 (4th ed.) ; see also, cf.,United States v. Walgreen Co. , 846 F.3d 879, 881 (6th Cir. 2017) (describing that " ‘particular’ allegations of fraud may demand different things in different contexts."). The Six......
  • United States ex rel. Ibanez v. Bristol-Myers Squibb Co.
    • United States
    • U.S. Court of Appeals — Sixth Circuit
    • 27 Octubre 2017
    ..., 655 F.3d at 471 ). Prather 's personal knowledge exception applies in limited circumstances. See United States ex rel. Hirt v. Walgreen Co. , 846 F.3d 879, 881 (6th Cir. 2017). In Chesbrough , an independent radiology consultant—alleging the radiology billings he reviewed were fraudulent—......
  • Request a trial to view additional results
1 firm's commentaries
  • Cases Highlight Ongoing Uncertainty, Complexities Of Rule 9(b) In FCA Context
    • United States
    • Mondaq United States
    • 4 Julio 2022
    ...v. Lexington Foot & Ankle Ctr. PSC, Civ. A. No. 5:17-129-DCR, 2018 U.S. Dist. LEXIS 93976, at *13 (E.D. Ky. June 5, 2018) (citing Hirt, 846 F.3d 879, 881 (6th Cir. 2017)) (alteration 20. Hirt, 846 F.3d at 881 (citation and internal quotation marks omitted); see also United States ex rel. Ib......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT